Accessibility Menu
 
Cel-sci logo

Cel-sci

(NYSEMKT) CVM

Current Price$3.47
Market Cap$29.35M
Since IPO (1992)-100%
5 Year-99%
1 Year-45%
1 Month-2%

Cel-sci Financials at a Glance

Market Cap

$29.35M

Revenue (TTM)

$0.00

Net Income (TTM)

$23.81M

EPS (TTM)

$-5.14

P/E Ratio

-0.68

Dividend

$0.00

Beta (Volatility)

1.25 (Average)

Price

$3.47

Volume

182

Open

$3.47

Previous Close

$3.47

Daily Range

$3.47 - $3.47

52-Week Range

$1.98 - $13.48

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cel-sci

Industry

Biotechnology

CEO

Geert R. Kersten, MBA

Headquarters

Vienna, VA 22182, US

CVM Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-212%

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

-1.47%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$29.35M

Shares Outstanding

8.46M

Volume

182

Short Interest

0.00%

Avg. Volume

54.84K

Financials (TTM)

Gross Profit

$3.89M

Operating Income

$24.81M

EBITDA

$20.88M

Operating Cash Flow

$17.12B

Capital Expenditure

$38.11M

Free Cash Flow

$17.16B

Cash & ST Invst.

$10.95M

Total Debt

$9.38M

Cel-sci Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$964.42K

+3.1%

Gross Margin

0.00%

N/A

Market Cap

$29.35M

N/A

Market Cap/Employee

$682.54K

N/A

Employees

43

N/A

Net Income

$5.47M

+22.7%

EBITDA

$4.40M

+25.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$4.35M

+32.8%

Accounts Receivable

$0.00

N/A

Inventory

$230.45K

-73.3%

Long Term Debt

$8.11M

-7.6%

Short Term Debt

$2.52M

+9.3%

Return on Assets

-1.04%

N/A

Return on Invested Capital

-1.30%

N/A

Free Cash Flow

$4.02M

+3.6%

Operating Cash Flow

$4.02M

+2.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
INMBINmune Bio, Inc.
$1.21-1.63%
BRNSBarinthus Biotherapeutics plc
$0.60+11.09%
PDSBPDS Biotechnology Corporation
$0.64+4.73%
FGENFibroGen, Inc.
$9.07-1.63%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
INTCIntel
$50.38+0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%

Questions About CVM

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.